EMBIOSYS INC.
Medtech · Private
Wearable garment device delivering induced electric field (iEF) therapy for triple-negative breast cancer treatment
- Grants
- $1.8M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development Of A Wearable, Non-invasive, Treatment Device For Metastatic Triple-negative Breast Cancer (tnbc) | $211,125 | |
| Federal grant | Department of Health and Human Services · Phase I · Development Of A Wearable, Non-invasive, Treatment Device For Metastatic Triple-negative Breast Cancer (tnbc) | $188,875 | |
| Federal grant | Department of Health and Human Services · Phase II · CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer | $1,379,442 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2033 | FLEX ORTHOPAEDICS, INC. | — | — |
| 2034 | SONOVANCE, INC. | — | — |
| 2035 | ENDOTAT BIOTECHNOLOGIES LLC | — | — |
| 2036 | EMBIOSYS INC. | — | — |
| 2037 | OLMEDA BIOSCIENCES LLC | — | — |
| 2038 | AIMLOXY LLC | — | — |
| 2039 | PERSISTENCE THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Wearable, Non-invasive Therapy Devicegranted
- Wearable, Non-invasive Therapy Deviceapplication
- Wearable, Non-invasive Device For Treating Solid Tumorsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.